Your browser doesn't support javascript.
loading
CLCN2 chloride channel mutations in familial hyperaldosteronism type II.
Scholl, Ute I; Stölting, Gabriel; Schewe, Julia; Thiel, Anne; Tan, Hua; Nelson-Williams, Carol; Vichot, Alfred A; Jin, Sheng Chih; Loring, Erin; Untiet, Verena; Yoo, Taekyeong; Choi, Jungmin; Xu, Shengxin; Wu, Aihua; Kirchner, Marieluise; Mertins, Philipp; Rump, Lars C; Onder, Ali Mirza; Gamble, Cory; McKenney, Daniel; Lash, Robert W; Jones, Deborah P; Chune, Gary; Gagliardi, Priscila; Choi, Murim; Gordon, Richard; Stowasser, Michael; Fahlke, Christoph; Lifton, Richard P.
Afiliação
  • Scholl UI; Department of Nephrology, Medical School, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. ute.scholl@charite.de.
  • Stölting G; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin Institute of Health, Berlin, Germany. ute.scholl@charite.de.
  • Schewe J; Institute of Complex Systems, Zelluläre Biophysik (ICS-4), Forschungszentrum Jülich, Jülich, Germany.
  • Thiel A; Department of Nephrology, Medical School, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Tan H; Department of Nephrology, Medical School, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Nelson-Williams C; Institute of Complex Systems, Zelluläre Biophysik (ICS-4), Forschungszentrum Jülich, Jülich, Germany.
  • Vichot AA; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
  • Jin SC; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.
  • Loring E; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
  • Untiet V; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.
  • Yoo T; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
  • Choi J; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
  • Xu S; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.
  • Wu A; Yale Center for Mendelian Genomics, New Haven, CT, USA.
  • Kirchner M; Institute of Complex Systems, Zelluläre Biophysik (ICS-4), Forschungszentrum Jülich, Jülich, Germany.
  • Mertins P; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Rump LC; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
  • Onder AM; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.
  • Gamble C; Endocrine Hypertension Research Center, University of Queensland Diamantina Institute, Greenslopes and Princess Alexandra Hospitals, Brisbane, Queensland, Australia.
  • McKenney D; Endocrine Hypertension Research Center, University of Queensland Diamantina Institute, Greenslopes and Princess Alexandra Hospitals, Brisbane, Queensland, Australia.
  • Lash RW; Proteomics Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Society and Core Unit of Proteomics, Berlin Institute of Health, Berlin, Germany.
  • Jones DP; Proteomics Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Society and Core Unit of Proteomics, Berlin Institute of Health, Berlin, Germany.
  • Chune G; Department of Nephrology, Medical School, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Gagliardi P; Nephrology, Le Bonheur Children's Hospital, Memphis, TN, USA.
  • Choi M; Cooper Clinic, PA, Fort Smith, AR, USA.
  • Gordon R; Peyton Manning Children's Hospital at St. Vincent, Indianapolis, IN, USA.
  • Stowasser M; Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Fahlke C; Division of Nephrology and Hypertension, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Lifton RP; Olin Teague Veterans Administration Hospital, Temple, TX, USA.
Nat Genet ; 50(3): 349-354, 2018 03.
Article em En | MEDLINE | ID: mdl-29403011
Primary aldosteronism, a common cause of severe hypertension 1 , features constitutive production of the adrenal steroid aldosterone. We analyzed a multiplex family with familial hyperaldosteronism type II (FH-II) 2 and 80 additional probands with unsolved early-onset primary aldosteronism. Eight probands had novel heterozygous variants in CLCN2, including two de novo mutations and four independent occurrences of a mutation encoding an identical p.Arg172Gln substitution; all relatives with early-onset primary aldosteronism carried the CLCN2 variant found in the proband. CLCN2 encodes a voltage-gated chloride channel expressed in adrenal glomerulosa that opens at hyperpolarized membrane potentials. Channel opening depolarizes glomerulosa cells and induces expression of aldosterone synthase, the rate-limiting enzyme for aldosterone biosynthesis. Mutant channels show gain of function, with higher open probabilities at the glomerulosa resting potential. These findings for the first time demonstrate a role of anion channels in glomerulosa membrane potential determination, aldosterone production and hypertension. They establish the cause of a substantial fraction of early-onset primary aldosteronism.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canais de Cloreto / Hiperaldosteronismo / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Infant / Male Idioma: En Revista: Nat Genet Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canais de Cloreto / Hiperaldosteronismo / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Infant / Male Idioma: En Revista: Nat Genet Ano de publicação: 2018 Tipo de documento: Article